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Abstract 
Objective To assess the impact of a food-based intervention on blood pressure (BP) in free-living South 
African men and women aged 50–75 years, with drug-treated mild-to-moderate hypertension. 
Methods A double-blind controlled trial was undertaken in eighty drug-treated mild-to-moderate 
hypertensive subjects randomised to an intervention (n 40) or control (n 40) arm. The intervention was 
8-week provision of six food items with a modified cation content (salt replacement (SOLO™), bread, 
margarine, stock cubes, soup mix and a flavour enhancer) and 500 ml of maas (fermented milk)/d. The 
control diet provided the same quantities of the targeted foods but of standard commercial composition 
and 500 ml/d of artificially sweetened cooldrink. 
Findings The intervention effect estimated as the contrast of the within-diet group changes in BP from 
baseline to post-intervention was a significant reduction of 6·2 mmHg (95 % CI 0·9, 11·4) for systolic BP. 
The largest intervention effect in 24 h BP was for wake systolic BP with a reduction of 5·1 mmHg (95 % CI 
0·4, 9·9). For wake diastolic BP the reduction was 2·7 mmHg (95 % CI −0·2, 5·6). 
Conclusions Modification of the cation content of a limited number of commonly consumed foods lowers 
BP by a clinically significant magnitude in treated South African hypertensive patients of low socio-
economic status. The magnitude of BP reduction provides motivation for a public health strategy that 
could be adopted through lobbying of the food industry by consumer and health agencies. 
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Abstract
Objective: To assess the impact of a food-based intervention on blood pressure
(BP) in free-living South African men and women aged 50–75 years, with drug-
treated mild-to-moderate hypertension.
Methods: A double-blind controlled trial was undertaken in eighty drug-treated
mild-to-moderate hypertensive subjects randomised to an intervention (n 40)
or control (n 40) arm. The intervention was 8-week provision of six food items
with a modified cation content (salt replacement (SOLOTM), bread, margarine,
stock cubes, soup mix and a flavour enhancer) and 500 ml of maas (fermented
milk)/d. The control diet provided the same quantities of the targeted foods but
of standard commercial composition and 500 ml/d of artificially sweetened
cooldrink.
Findings: The intervention effect estimated as the contrast of the within-diet
group changes in BP from baseline to post-intervention was a significant
reduction of 6?2 mmHg (95 % CI 0?9, 11?4) for systolic BP. The largest interven-
tion effect in 24 h BP was for wake systolic BP with a reduction of 5?1 mmHg
(95 % CI 0?4, 9?9). For wake diastolic BP the reduction was 2?7 mmHg (95 % CI
20?2, 5?6).
Conclusions: Modification of the cation content of a limited number of commonly
consumed foods lowers BP by a clinically significant magnitude in treated South
African hypertensive patients of low socio-economic status. The magnitude of BP
reduction provides motivation for a public health strategy that could be adopted
through lobbying of the food industry by consumer and health agencies.
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South Africans
In South Africa, the prevalence of hypertension in the adult
black population is 24?4%. Diagnosis and management
of the condition in this group is particularly poor(1–5). The
daily salt intake (7?8 g) in this group(6) exceeds the
recommended maximum of 6 g/d(7) while K intake is low
(between 50 and 60mmol/d)(8,9) and falls far below the
intake that would be required to keep the Na:K ratio close
to one, as recommended by the WHO(10). Furthermore,
low habitual dietary intakes have been reported for Ca and
Mg(11). These data indicate a need for population-based
approaches to change dietary behaviour for the prevention
and management of hypertension.
The DASH trial provided evidence that a dietary pattern
that is rich in fruit, vegetables and low-fat dairy products
can reduce blood pressure (BP) significantly(12). The
follow-up DASH-Sodium study demonstrated additional
BP-lowering benefits of salt restriction over and above the
merits of the DASH diet(13).
In the South African context, promotion of the DASH
eating plan is unrealistic due to high levels of food
insecurity among the poor(14) and the very low intake of
fruit, vegetables and dairy products(15). Identification of
an affordable, sustainable and culturally acceptable dietary
pattern is paramount to compliance in this group. It
has been proposed that the way to lower salt intake on
a population level is through the reduction of the Na
content of processed foods(16,17). Bread is a staple but
also provides the highest proportion (41–73 %) of non-
discretionary Na in the diets of black South Africans(8),
thus is an obvious target. We hypothesise that a moderate
reduction in Na intake, in the presence of an increased
intake of K, Mg and Ca in commonly consumed foods,
*Corresponding author: Email karenc@uow.edu.au r The Authors 2008
will reduce BP significantly in black South Africans with
hypertension.
Subjects and methods
We conducted a randomised, double-blind, controlled
trial to investigate the impact of an 8-week feeding study
(in which Na intake is decreased, and K, Mg and Ca
intake is increased) on BP in mild-to-moderate hyper-
tensive black South Africans (Fig. 1). The participants
were black residents of a Cape Town township (Langa),
aged 50–75 years, with drug-treated mild-to-moderate
hypertension (systolic BP # 160 mmHg and diastolic
BP # 95 mmHg) were eligible. Exclusion criteria included
taking two or more diuretics; taking furosemide for cardiac
failure; cerebral infarction or haemorrhage; renal impair-
ment (serum creatinine . 114?4 mmol/l or creatinine
clearance , 50 ml/min (Cockroft–Gault equation)(18)),
three or more alcoholic drinks per day; type 1 diabetes
mellitus; impaired cognitive function(19,20); incontinence;
and BMI . 45kg/m2. Subjects with severely uncontrolled
hypertension (i.e. .160/95 mmHg) were excluded. Those
with uncontrolled diabetes and/or hypertension were
referred to health-care providers during the run-in period.
Sample size calculations used the nQuery Advisor
5?0 program. Assuming a reduction in systolic BP of
6?3mmHg,(21) an SD of 10mmHg, and a two group t-test
with a 0?050 two-sided significance level and 80% power,
a sample size of forty-one subjects per arm (n 82 in total)
was required. The study was undertaken in two phases
(May–December 2004 and January–July 2005). Recruitment
and enrolment took place at a church-based setting
and a community health centre, and advertisements were
placed in the local community newspaper. Eligible subjects
who completed a 3-week run-in period were randomised
(Fig. 2).
In an industry–academia partnership, the Na content and
K, Mg and Ca content were modified in five commonly
consumed food items: brown bread, margarine, stock
cubes, soup mixes and Aromat (monosodium glutamate-
based flavour enhancer)(22). The intervention comprised
these modified foods plus a salt replacement (SoloTM) and
500ml of maas (fermented milk commonly eaten) daily. The
control diet provided the same foods but of standard
commercial composition, as well as artificially sweetened
cold drink instead of maas. The subjects rated the palat-
ability of trial foods using a 5-point Likert scale rating(23).
Subjects were instructed to consume their usual amounts
of food(8) and sufficient food was provided for the whole
family. Based on laboratory-determined chemical food ana-
lyses, compared to control foods, the intervention foods were
planned to provide 41% less Na (100?3 v. 170?3mmol/d),
826 % more K (70?9 v. 8?6 mmol/d), 388 % more Ca (857 v.
221 mg/d) and 368 % more Mg (13?8 v. 3?7 mmol/d).
Both study participants and fieldworkers were blinded
to diet group allocation of subjects. A single dietitian was
responsible for food-packing and all food was locked and
sealed in large shopping bags, labelled only with parti-
cipants’ names and contact details. A driver delivered the
food three times a week.
Clinical measurements and biological samples were taken
and questionnaires administered by trained fieldworkers in
either Xhosa or English before, during and after the inter-
vention at the time points, as shown in Fig. 1. Height was
recorded using a stadiometer and weight recorded on a
calibrated scale, to the nearest 100g. BMI was calculated
as weight (kg)/(height (m))2. Body fat was measured using
a standard tetrapolar 50kHz bioimpedance monitor
(BodystatTM), with the subject lying supine. The prediction
equations include body weight, height, age and gender.
Urinary and fasting blood parameters were analysed by
National Health Laboratories Institute, based at Groote
Schuur Hospital, using standard methods and quality
BP (Omron)
BP (Omron)
BP (Omron)
24 h urine
24 h dietary recall
BP (Omron)
24 h urine
24 h dietary recall
Anthropometry
Blood analyses
24 h ambulatory BP
BP (Omron)
24 h urine
24 h dietary recall
24 h ambulatory BP
Randomization
8-week intervention3-week run-in
Week 4 Week 8
 24 h urine
 24 h dietary recall
Control diet (n 40)
Reduced Na, High K, Mg,
Ca diet (n 40)
Visit 1 Visit 2 Visit 3
Fig. 1 Scheme of study design (BP, blood pressure)
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control procedures. Completeness of 24 h urine collection
was assessed as at least 500 ml volume and a urinary
creatinine value $0?18 mmol/kg lean body mass/d for
men or $0?12 mmol/kg lean body mass/d for women(24).
Urinary analyses included Na, K, Mg, Ca and creatinine.
A questionnaire included sociodemographic data,
medical history and self-perceived health status using
an adapted EQ-5D instrument(25). Subjects were asked to
bring all prescribed medications for recording by trained
nurses. Subjects completed interviewer-administered 24h
dietary recalls(26) using the South African validated Dietary
Assessment Education Kit(27) to quantify food portion sizes.
Recorded foods were converted to gram weights and
daily nutrient intake using the Medical Research Council
(MRC) Food Quantities Manual(28) and Foodfinder III
computerised dietary assessment program based on
national food tables(29). Dietary compliance was monitored
using data from 24h recalls and 24h urinary electrolyte
concentrations, and returned salt and Aromat shakers were
weighed weekly. Physical activity levels were measured
using the Yale Physical Activity Survey instrument(30).
The primary outcome variable was resting office BP,
measured according to the American Heart Association
Recommendations for BP Determination(31), using a
validated automated method with pre-set inflation(32)
(Omron M4-I BP monitor; Omron Matsusaka Co., Ltd,
Japan). A large cuff was used for arm circumferences
$33 cm. BP was measured three times on each occasion
and an average of the second and third measurements
taken for analyses. BP was measured weekly four times
before the initiation of the intervention and the mean
taken as baseline BP (‘Pre’). Thereafter, BP was measured
on two occasions each at weeks 4 and 8.
In addition, average 24 h ambulatory systolic and dia-
stolic BP and awake and asleep BP were measured at
baseline and during the final week of the intervention,
using an Oscar 2 (SunTech Medical) Ambulatory Blood
Pressure Monitor (ABPM), which has been validated
and endorsed by the British Hypertension Association as
being reliable for use in clinical trials(33).
The Research and Ethics Committee of the University of
Cape Town approved the study protocol. The trial was
registered with the South African Department of Health
National Research Register (DOH-27-0806-1394). Written
informed consent was obtained from all participants who
were closely monitored for adverse effects.
Intention-to-treat analyses were performed. For analysis
of office (Omron) BP, linear regression was performed to
assess the intervention effect at weeks 4 and 8. The model
had indicators for diet group, phase, time and interaction
effects for testing the consistency of the intervention
effect over the two phases and the expected differential
change in BP over time in the two diets. The analysis
accounted for the repeated nature of the BP measure-
ments within each subject by using the generalised
estimation equation (GEE) approach. From this model,
a contrast in Omron BP measurements for the change
from baseline to the intervention period between the
diet groups was estimated. Using a method described
by Rochan (1995)(34) to adjust for a covariate which is
observed post-randomisation, a seemingly unrelated
regression analysis was used to model the BP outcomes
and change to anti-hypertensive medication (yes or no
response) on diet group and phase. The SUR program of
STATA was used for this analysis.
For analysis of 24 h ABPM, multivariate linear regres-
sion was used to assess the intervention effect. The vector
of 24 h ABPM measurements (systolic and diastolic BP for
average, wake, sleep and mean arterial pressure (MAP))
obtained at the end of the intervention period was
Assessed for eligibility (n 225)
Randomised (n 92)
Allocated to intervention (n 47) Allocated to control (n 45)
Analysed (n 40)Analysed (n 40)
Excluded (n 133)
Not meeting inclusion criteria (n 121)
Received allocated intervention (n 42)
Refused to participate (n 5)
Lost to follow-up (n 1 drop-out) Lost to follow-up (n 1 drop-out)
Discontinued intervention; stroke (n 1)
Received allocated intervention (n 41)
Refused to participate (n 4)
Refused to participate (n 8)
Unable to comply with urine collection instructions (n 4)
Fig. 2 Recruitment and screening of subjects
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modelled on indicator variables for diet and phase as
well as the baseline values of average 24 h systolic and
diastolic BP and 24 h MAP. The intervention effect with
95 % CI was estimated for the pooled data. Regression
analyses were also conducted using the SUR model in
order to account for medication change as a post-
randomisation covariate.
Change in other variables between baseline and post-
intervention was assessed using paired t-tests within diet
groups. Between-diet group differences were investigated
using independent t-tests. Multivariate linear regression
modelling for change in systolic and diastolic BP included
the following variables in the model: change in 24h urinary
excretion of Na, K, Mg and Ca; diet group; and the inter-
action effects of diet and urinary cation changes.
Results
During the intervention, one subject each in the inter-
vention and control groups dropped out and one inter-
vention group participant had a stroke, leaving eighty
subjects (n 40 per diet group; Fig. 2). Baseline socio-
demographic characteristics, BP and lifestyle factors
associated with BP control are shown in Table 1. Mean
age was 61?7 (SD 7?9) years and the control group was on
average 5 kg heavier than the intervention group.
The average number of prescribed anti-hypertensive
medications was 2?1 (SD 0?9) with the most common
medication being low-dose thiazide diuretics (76?2 %
participants), followed by ACE inhibitors (55?0 %). Thirty
per cent were on monotherapy.
Table 1 Baseline sociodemographic characteristics of the sample, lifestyle factors associated with hypertension control and
self-perceived health status
Intervention (n 40) Control (n 40)
Mean SD Mean SD P-value-
Age (years) 61?8 6?6 60?4 7?4 0?355
Range 50–76 50–75
Female/male ratio 33/7 34/6
Literacy rate (ability to read) (%) 97?5 95?0 0?222
Highest level of education achieved (n) 0?280
#7 years of schooling (primary) 10 15
8–12 years of schooling (secondary) 26 20
Tertiary/diploma 4 5
Employment status (n) 0?740
Employed 5 8
Unemployed/housewife 12 10
Social (old age) grant 21 18
Disability grant 2 4
Type of housing (n) 0?070
Formal housing (privately owned) 17 20
Council/core house 13 4
Informal shack 2 8
Hostel 8 8
Housing density (no. of persons/no. of rooms) 2?77 1?96 2?48 1?71 0?543
Previously diagnosed chronic conditions (n)
Heart attack or angina 6 3 0?289
Any other heart condition 4 2 0?396
Hypercholesterolaemia 1 3 0?305
Asthma 6 3 0?762
Peripheral vascular disease 2 2 1?000
Diabetes* 7 7 0?556
Self-rated health scale 0?355
Mean score 65?7 19?0 65?4 20?7
Range 10–100 30–100
Tobacco use (n) 0?404
Current tobacco use 4 3
Past smoker 2 0
Physical activity (kJ/week) 7641 5074 8502 6496 0?329
Weight (kg) 83?3 13?7 88?8 15?5 0?990
BMI (kg/m2) 32?9 5?8 35?3 6?0 0?077
Lean mass (%) 54?7 9?1 51?9 9?0 0?964
Fat mass (%) 45?3 9?1 48?1 9?0 0?183
Systolic BP (mmHg) 133?9 14?6 135?4 16?7 0?666
Diastolic BP (mmHg) 79?8 8?6 82?3 7?5 0?180
Average 24 h systolic BP (mmHg) 135?0 13?5 138?9 17?0 0?254
Average 24 h diastolic BP (mmHg) 79?2 8?7 80?4 8?9 0?547
BP, blood pressure.
*Data obtained from medication history during run-in period, plus one newly diagnosed diabetic in low salt group of phase 1.
-Independent t-test for difference between groups; Fisher’s exact test for categorical data.
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Compared to mean Omron BP at baseline, mean values
estimated at weeks 4 and 8 are shown in Fig. 3. The figure
demonstrates that most of the intervention effect had
already occurred within the first 4 weeks of the intervention.
No significant difference was found in change from
baseline between weeks 4 and 8 for both systolic and
diastolic BP (results not shown). The average BP of weeks
4 and 8 (‘Post’) is shown in Fig. 4. The estimated inter-
vention effects, which included diet and phase in the
regression modelling, are shown in Table 2. Mean post-
intervention Omron systolic BP in the intervention group
was 6?2 mmHg (P 5 0?021) lower than in the control
group with no significant between-group difference in
diastolic BP. For ABPM the significant reduction in aver-
age (4?5 mmHg) and wake (5?1 mmHg) systolic BP was
also due to the intervention.
The SUR modelling, which adjusted for medication
change (yes or no), provided similar results but found a
mean between-group change in systolic BP from baseline to
post-intervention of 26?43mmHg (95% CI 211?2, 21?7;
P 5 0?008) and a non-significant change in diastolic BP of
20?988mmHg (95% CI 23?23, 1?47; P 5 0?464). For 24h
BP, diet-related reductions in average systolic and diastolic
BP were both significant (P , 0?05) at 24?91mmHg (95%
CI 29?2, 20?7) and 22?65mmHg (95% CI 25?13, 20?17),
respectively. Change in systolic BP during waking hours
was the 24h BP parameter found to have the greatest
reduction associated with the intervention effect (mean 5
25?59 (SEM 5 2?31) mmHg; P 5 0?015).
Twenty-two subjects (n 13 (intervention); n 9 (con-
trol)) had a change in anti-hypertensive medication
during the trial. No significant difference in the profile
of medication change (i.e. medications added (n 11);
removed (n 6); combination of both (n 5); or no change
(n 58)) was found between diet groups (Fisher’s exact
test; P 5 0?095). At baseline, there was no difference in
systolic BP between those who had no change to their
anti-hypertensive medication during the trial (n 58) and
those who did have medication changes (n 22) (133?8
(SD 16?8) v. 137?0 (SD 11?9) mmHg, respectively; P 5 0?2105).
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Fig. 3 (a) Mean systolic blood pressure (BP) (Omron) at
baseline (week 0), week 4 and week 8 of intervention,
according to diet group allocation (error bars reflect SEM). (b)
Mean diastolic BP (Omron) at baseline (week 0), week 4 and
week 8 of intervention, according to diet group allocation (error
bars reflect SEM) ( , control; , low salt)
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Fig. 4 Mean systolic and diastolic blood pressure (BP) at pre
(baseline) and post (mean of week 4 and week 8 measure-
ments), according to diet group allocation (error bars reflect
SEM) ( , control; , low salt)
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Similarly, there was no baseline difference in 24 h systolic
BP between groups that had medication changes com-
pared to those that did not (135?6 (SD 15?6) v. 140?4
(SD 3?1) mmHg, respectively; P 5 0?1061). Results for
diastolic BP were similar.
There were no baseline differences in reported food
intake patterns between the two groups. During the
intervention, in both groups reported energy and carbo-
hydrate intake increased significantly but reported
protein, fat and cholesterol intake remained unchanged.
Reported dietary Na intake increased in the control
group, but was unchanged in the intervention group
(Table 3). Reported K, Ca and Mg intake significantly
increased in the intervention group, but not in the control
group. A significant between-group difference was found
for change in intake between intervention and baseline
for Na, K, Ca and Mg. Mean difference in Na/4200 kJ was
a reduction of 2104 (SD 418) mg/4200 kJ for the inter-
vention group and an increase of 558 (SD 1058) mg/
4200 kJ for the control group, yielding a net between-diet
difference of 2661 (SD 805) mg/4200 kJ (P 5 0?0006). The
significant mean increase of dietary Ca intake of 310 mg/d
Table 2 Estimated intervention effects for office BP and 24 h ABPM
95 % CI of difference
Mean net difference* (mmHg) SEM Lower Upper P-value of contrast
Office BP (Omron)
Systolic BP 26?194- 2?636 211?442 20?945 0?021
Diastolic BP 20?595- 1?216 23?019 1?829 0?626
24 h ABPM
Average systolic BP 24?527-
-
2?269 29?047 20?006 0?050
Average diastolic BP 22?494-
-
1?338 25?160 0?173 0?066
Wake systolic BP 25?138-
-
2?404 29?928 20?348 0?036
Wake diastolic BP 22?661-
-
1?457 25?565 0?242 0?072
Sleep systolic BP 23?465-
-
2?540 28?527 1?596 0?177
Sleep diastolilc BP 21?790-
-
1?679 25?134 1?555 0?290
MAP 23?113-
-
1?583 26?267 0?040 0?053
BP, blood pressure; ABPM, ambulatory blood pressure monitor; MAP, mean arterial pressure.
*Low-salt 2 control.
-Contrast between groups of pre to post changes. Pre 5 mean of run-in visits (1, 2, 3) and visit 4 (day 1 of intervention); post 5 mean of week 4 and week 8
measurements.
-
-
Contrast between groups at week 8 adjusted for baseline covariates.
Table 3 Reported daily dietary intake at baseline and during the intervention, according to diet group (values are in mean and SD)
Baseline Post Difference- Mean difference (intervention2control)
Nutrient Mean SD Mean SD Mean SD P-value* Mean SD
Energy (kJ)
Intervention 6441 1569 7370 2075 929 1840 0?0267 2145 1973
Control 6433 1903 7505 2436 1074 2186 0?0309
Protein (g)
Intervention 54 16 62 20 8 18 0?0488 6?5 26?3
Control 57 30 59 20 1?5 25?2 0?7933
Fat (g)
Intervention 48 18 52 19 4?3 18?4 0?3039 22?6 24?7
Control 51 23 57 25 6?8 23?9 0?2043
Carbohydrate (g)
Intervention 200 55 247 85 46 72 0?0051 25?6 77?8
Control 194 60 246 96 52 80 0?0049
Na (mg)-
-
Intervention 1694 724 1778 916 85 826 0?6487 21167 1532*
Control 1912 922 3164 1757 1252 1403 0?0002
Ca (mg)-
-
Intervention 385 180 822 353 436 280 ,0?0001 310 392**
Control 407 298 533 377 126 340 0?1009
K (mg)-
-
Intervention 1832 517 2729 977 897 781 ,0?0001 867 890***
Control 1826 588 1857 799 31 707 0?8420
Mg (mg)-
-
Intervention 223 64 307 103 84 86 ,0?0001 71 89**
Control 222 65 235 91 14 79 0?4446
Baseline 5 average of visits 1, 2 and 3 during run-in; Post 5 average of weeks 4 and 8.
*P , 0?01; **P , 0?001; ***P , 0?0001 for differences between diet groups.
-Difference 5 Post2Baseline.
-
-
For conversion to mmol/d, divide by following factors: 23 (Na); 40 (Ca); 39 (K); 24 (Mg).
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in the intervention compared to the control group was
explained by a reported increased intake of maas from
33 g/d at baseline to 275 g/d in the intervention group.
There were no between-group differences for the
household quantity of either salt or Aromat used during
the trial. The low-salt margarine (87?5 %) and the salt
replacement (75 %) were reported to taste less acceptable
than the normal products; however, other intervention
food items were preferred to the regular consumed vari-
eties. The control group reported that they preferred all of
the food items provided, despite the fact that the foods
were unaltered in cation content.
The 24 h urinary excretion data found that there was a
trend for a reduced Na excretion in the intervention
group, but this was not significantly lower than that of the
control group (Table 4). Significant between-group dif-
ferences after the intervention were found for urinary K
and Mg excretion with no change in urinary Ca excretion.
No change between baseline and end of intervention
was found for weight, BMI, % body fat, self-perceived
health status score or physical activity in either the groups.
Discussion
This study demonstrates a public health intervention that
can achieve a clinically significant reduction in systolic BP
in moderately hypertensive subjects on treatment living in
a low-income community setting in South Africa through
the dietary manipulation of seven commonly consumed
processed foods. The study also illustrates that this will
require partnerships between public health agencies and
the food industry.
An important difference between the design of our
study and that of other food-based BP trials(12,13,35,36) is
that we did not attempt to alter habitual food patterns, in
either quantity or quality.
The BP-lowering effect we found for systolic BP was
similar to or higher than responses reported in meta-
analyses of randomised trials of either Na reduction (n 40
trials) or K supplementation (n 27 trials)(37). Our results
are also similar to the findings of a 24-week randomised
trial in 55–75-year-old untreated Dutch hypertensives in
which the same salt replacement product was used(38).
The DASH 8-week feeding study, however, demonstrated
a much greater BP reduction (213?2/26?1 mmHg) in the
subgroup analyses for African-Americans with hyperten-
sion(13). All food and beverages were provided in the
DASH study and subjects consumed one supervised meal
a day at the research centre, thus enhancing compliance.
In trials such as PREMIER(36), where patients are required
to follow the DASH diet while purchasing their own food,
the recommended number of daily servings of fruit and
vegetables could not be met. Few food-based trials have
been conducted in developing countries. A randomised
8-week crossover study of low-salt and high-salt intakes
conducted in Jamaica and Nigeria demonstrated a mean
between-diet change in systolic BP of approximately
5 mmHg in both country sites(39). In the Nigerian site,
participants were able to achieve substantial Na reduc-
tions by simply not adding salt during meal preparation.
The dietary intervention achieved an overall increase in
K, Mg and Ca but surprisingly without a substantial
decrease in the Na content of the diet, at least according
to the urinary excretion results. The intervention diet was
calculated to provide a decrease in dietary Na intake of
70 mmol/d, compared to the control diet (41 % reduc-
tion). The 24 h dietary recall data found a significant
increase in energy and carbohydrate intake in both diet
and control groups, explained by increased bread con-
sumption in both groups during the trial. It appears that
the increased bread intake displaced other staple foods,
notably maize meal, to which large quantities of salt are
generally added (de Goede J, van der Meij B (2001) Risk
factors of obesity in black, female Community Health
Workers living in an urban area in South Africa. M.Sc.
Dissertation. Wageningen UR, unpublished).
Table 4 Mean and SD 24 h urinary excretion of Na, K, Mg and Ca (mmol/d)
Baseline Post-intervention Mean change from baseline- Mean between-diet group difference-
-
Diet group Mean SD Mean SD Mean SD Mean SD
Urinary Na (mmol/24 h)
Intervention 171?7 53?7 154?3 64?0 214?6 54?4 28?7 46?9
Control 173?2 52?4 169?3 57?7 25?9 54?3
Urinary K (mmol/24 h)
Intervention 52?3 11?0 71?7 25?5 120?0 22?7** 124?6 16?5**
Control 52?9 14?7 48?6 14?3 24?6 14?8
Urinary Mg (mmol/24 h)
Intervention 2?86 0?93 3?70 1?57 10?88 1?20 10?68 0?88*
Control 2?79 0?96 3?00 1?07 10?19 0?81
Urinary Ca (mmol/24 h)
Intervention 1?92 1?35 2?15 1?61 10?27 1?00 20?05 0?91
Control 1?39 1?72 1?72 1?65 10?32 1?11
Baseline 5 Average of run-in visits 1,2,3; Post 5 average of weeks 4 and 8.
*P , 0?05; **P , 0?001.
-Baseline minus Post.
-
-
Intervention diet minus Control.
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The discrepancies between the urinary excretion and
dietary intake data may be related to methodological
difficulties associated with the collection of both these
variables. The dietary data found a significant between-
group reported difference in Na intake of 51 mmol/d, and
this difference remained even after controlling for an
increased energy intake during the intervention.
It was not the purpose of this study, nor was it pow-
ered, to determine the contribution of each dietary
manipulation (i.e. decreased Na and increased K, Mg and
Ca) to BP reduction, but rather to demonstrate effective-
ness of a practical composite dietary approach that could
be of public health significance in the target population.
However, regression modelling suggests that increased
urinary K excretion contributed most to the BP-lowering
impact of the intervention (data not shown).
Dairy foods are an important component of the DASH
diet(12) and Ca supplementation is associated with a
modest reduction in BP (average of 21?86/20?99mmHg)
with a slightly higher reduction in people with Ca intakes
below 800mg/d (22?63/21?30mmHg)(40). In the present
study, participants in the intervention group did not
manage to consume the recommended additional 500g of
maas (fermented milk)/d that was provided and reported
about half of this intake, presumably because it was shared
with other household members. It is recommended
that further dietary BP studies be conducted in popula-
tions with habitually low-Ca intakes, to compare the
BP-lowering effect of an increased intake of dairy foods
as compared to other strategies such as Na reduction.
In effect, our trial simulated the high-Na arm (150mmol
Na/d) of the DASH-Sodium trial(15). Urinary K excretion of
subjects in the low-salt arm increased during the trial to
similar levels as described for subjects following the DASH
diet in both the original DASH study (74?5mmol/d) and the
follow-up DASH-Sodium study (75?0mmol/d). Urinary Mg
levels rose to similar concentrations (4?03mmol/d), but
urinary Ca was considerably lower than DASH study parti-
cipants (3?64mmol). We achieved similar BP reductions
between diet-control groups as those reported in partici-
pants in the high-Na arm of the DASH-Sodium study. Thus,
simply by changing the cation content of five commonly
eaten foods, providing a salt replacement, and the daily
addition of a fermented milk drink, the effects of the DASH
diet can be achieved in South African black treated hyper-
tensive subjects who consume a high salt intake.
On a population level, it is estimated that the BP-lowering
effect of this dietary intervention would result in a 20%
reduction in the number of deaths attributed to high BP,
preventing more than 9000 deaths in one year (Rosana
Norman, personal communication, based on secondary
analysis of the South African Demographic and Health
Survey data(41) to estimate the disease burden attributable to
high BP in South Africa for the year 2000(42)).
A limitation of the study is that the intervention
effect was calculated using the mean of four repeated
measurements for the baseline measure and the mean of
only two repeated measurements (week 4 and week 8) as
the ‘post’ BP measure. The large variability in BP change
far exceeded that reported in the DASH study(43).
The study aimed to demonstrate effectiveness of a
community-based dietary intervention, rather than its
efficacy; therefore, only treated hypertensives were
included in the study. We considered it to be unethical to
ask participants to stop their anti-hypertensive medication
for almost 6 months since the target population is known
to be at high risk of cerebrovascular disease. It is logisti-
cally not feasible to recruit a sample of untreated hyper-
tensives in the South African context and in reality most
hypertensive patients will be taking anti-hypertensive
medication when they start making dietary changes to
further improve their BP control. In line with the national
guidelines for the management of hypertension in the
primary health-care setting that recommend diuretic
agents as the first-line drug for all patients with hyper-
tension(44,45), 86 % of participants were being prescribed
diuretics with thiazide-type diuretics, the cheapest anti-
hypertensive agent available, being the most commonly
used agent. Individuals who were taking more than one
diuretic were excluded as this is considered to be inappro-
priate management, based on national and international
therapeutic guidelines. Our inclusion strategy is in line
with international drug trials in hypertension that currently
enter patients already on multiple anti-hypertensive drugs,
such as the VALUE Trial(46).
The change in BP medication during the trial was
similar between the intervention and control groups and
did not impact on the study outcomes. The reported
results provide pragmatic estimates of the effect of the
intervention in general, including the effect over time (the
study was conducted in two phases) and the effect over
all medication adjustments. The important message from
this trial conducted in a low-income community setting is
that, regardless of medication change, changes in diet can
have beneficial outcomes for systolic BP.
Generalisability of the results warrants consideration.
To facilitate the practical delivery of the foods, partici-
pants were recruited from only one geographical area,
Langa, one of the oldest and more established peri-urban
townships of Cape Town, which has an estimated
population of 46 505, mostly Xhosa-speaking Africans(47).
Good BP control is rarely achieved in this high-risk group
which may be attributed to socio-economic factors, such
as failure to return to health-care centres for follow-up
visits due to transport costs and time involved, patients’
lack of knowledge of the disease and its outcomes, and
poor service delivery at primary health-care level in South
Africa(48,49). Extrapolation of the findings to the normo-
tensive population and to those with severe hypertension
cannot be assumed. Similarly, the inclusion of mostly
obese women, and few men, limits the generalisability
of the results to other sectors of the target population.
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Further, the relatively short duration of the trial (8 weeks)
raises questions regarding compliance with the dietary
changes over the longer term.
Conclusion
This randomised controlled trial provides evidence that
manipulation of the Na, K and Mg content of commonly
consumed processed foods, together with the provision of
a salt replacement and daily consumption of 500ml fer-
mented milk, lowers BP in free-living, black South Africans
with moderate hypertension who were using medication.
The South African food industry needs to be lobbied by
consumers, the Department of Health and other health
agencies to lower the Na content of their products (pre-
ferably while concurrently increasing K), particularly in
staple foods such as bread, in order to lower BP.
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